Subscribe to RSS

DOI: 10.1055/s-0045-1811583
Comparison of Cardiac MR with PET CT in Evaluation of Myocardial Viability: Single-Center Experience
Authors

Abstract
Aims and Objectives
The aim of this study was to compare the efficacy of various cardiac magnetic resonance imaging (MRI) parameters in assessing myocardial viability with positron emission tomography–computed tomography (PET-CT) as the gold standard.
Materials and Methods
This was a prospective analytical study comprising 28 adult patients with perfusion/metabolism matched or mismatched defects in PET-CT. These patients were taken up for MR evaluation, mainly assessing end-diastolic wall thickness (EDWT), regional wall motion abnormalities, and late gadolinium enhancement (LGE) for infarcted tissue. EDWT was measured manually and using semiautomatic software, and means were calculated.
Results
Of 448 (28 × 16) myocardial segments, 6% (n = 27) of the segments were considered not viable with matched defect, 56.5% (n = 253) were normal, and 37.5% (n = 168) were hibernating according to PET-CT. 51.1% (n = 86) of the hibernating segments showed no wall motion and 48% (n = 82) showed some wall motion, with a sensitivity of 66.03% (p < 0.001). There is good concordance of motion abnormalities detected using tagging with LGE. LGE and EDWT showed good sensitivity, 91.7 and 89.5%, respectively, as compared with PET CT in identifying viable but hibernating myocardium.
Conclusion
MRI parameter shows increased specificity and positive predictive value in identifying non-viable myocardium compared with PET/CT. All parameters had good sensitivity in identifying hibernating myocardium but had significantly low specificities.
Clinical relevance Cardiac MRI, when used in combination with PET CT, improves the sensitivity in identifying the viable but hibernating myocardium.
Publication History
Article published online:
19 September 2025
© 2025. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med 2016; 4 (13) 256-256
- 2 Rosamond W, Flegal K, Furie K. et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117 (04) e25-e146
- 3 Lloyd-Jones D, Adams RJ, Brown TM. et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 2010; 121 (07) 948-954
- 4 Krishnan MN. Coronary heart disease and risk factors in India - on the brink of an epidemic?. Indian Heart J 2012; 64 (04) 364-367
- 5 Wagner A, Mahrholdt H, Holly TA. et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003; 361 (9355) 374-379
- 6 Lund GK, Stork A, Saeed M. et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology 2004; 232 (01) 49-57
- 7 Ibrahim T, Bülow HP, Hackl T. et al. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol 2007; 49 (02) 208-216
- 8 Kaul S. The role of capillaries in determining coronary blood flow reserve: Implications for stress-induced reversible perfusion defects. J Nucl Cardiol 2001; 8 (06) 694-700
- 9 Baer FM, Theissen P, Schneider CA. et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31 (05) 1040-1048
- 10 Patel MR, White RD, Herfkens RJ. et al. Appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation. J Am Cardiol 2013; 61: 2207
- 11 Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”. J Am Coll Cardiol 1986; 8 (06) 1467-1470
- 12 Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117 (01) 211-221
- 13 Conti CR. The stunned and hibernating myocardium: a brief review. Clin Cardiol 1991; 14 (09) 708-712
- 14 Hesse B, Tägil K, Cuocolo A. et al; EANM/ESC Group. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005; 32 (07) 855-897
- 15 Beanlands RSB, Ruddy TD, deKemp RA. et al; PARR Investigators. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 2002; 40 (10) 1735-1743
- 16 Slart RHJA, Bax JJ, de Boer J. et al. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2005; 32 (08) 972-979
- 17 Hunold P, Jakob H, Erbel R, Barkhausen J, Heilmaier C. Accuracy of myocardial viability imaging by cardiac MRI and PET depending on left ventricular function. World J Cardiol 2018; 10 (09) 110-118
- 18 Selvanayagam JB, Kardos A, Francis JM. et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004; 110 (12) 1535-1541
- 19 Tomlinson DR, Becher H, Selvanayagam JB. Assessment of myocardial viability: comparison of echocardiography versus cardiac magnetic resonance imaging in the current era. Heart Lung Circ 2008; 17 (03) 173-185
- 20 Krittayaphong R, Laksanabunsong P, Maneesai A. et al. Comparison of cardiovascular magnetic resonance of late gadolinium enhancement and diastolic wall thickness to predict surgery. J Cardiovasc Mgnt 2008; 10: 1-11